ILIXADENCEL

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Name

Type

Language

CELL THERAPY CONSISTING OF PRO-INFLAMMATORY MONOCYTE-DERIVED DENDRITIC CELLS (MODCS), ISOLATED FROM AN ALLOGENEIC HUMAN HEALTHY BLOOD DONOR AND EX-VIVOSTIMULATED WITH RESIQUIMOD (R848), POLYINOSINIC-POLYCYTIDYLIC ACID (POLY(I:C)) AND INTERFERON GAMMA (IF

Preferred Name

English

ILIXADENCEL

Official Name

English

ilixadencel [INN]

Common Name

English

Ilixadencel [WHO-DD]

Common Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

864821

Created by admin on Wed Apr 02 10:43:08 GMT 2025 , Edited by admin on Wed Apr 02 10:43:08 GMT 2025

FDA ORPHAN DRUG

788320

Created by admin on Wed Apr 02 10:43:08 GMT 2025 , Edited by admin on Wed Apr 02 10:43:08 GMT 2025

FDA ORPHAN DRUG

796120

Created by admin on Wed Apr 02 10:43:08 GMT 2025 , Edited by admin on Wed Apr 02 10:43:08 GMT 2025

Code System Code Type Description

INN

10532

Created by admin on Wed Apr 02 10:43:08 GMT 2025 , Edited by admin on Wed Apr 02 10:43:08 GMT 2025

PRIMARY

FDA UNII

PY29292DVJ

Created by admin on Wed Apr 02 10:43:08 GMT 2025 , Edited by admin on Wed Apr 02 10:43:08 GMT 2025

PRIMARY

NCI_THESAURUS

C99902

Created by admin on Wed Apr 02 10:43:08 GMT 2025 , Edited by admin on Wed Apr 02 10:43:08 GMT 2025

PRIMARY

SMS_ID

100000179976

Created by admin on Wed Apr 02 10:43:08 GMT 2025 , Edited by admin on Wed Apr 02 10:43:08 GMT 2025

PRIMARY

ACTIVE MOIETY


					PY29292DVJ